Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback